IN2013MU03847A - - Google Patents
Info
- Publication number
- IN2013MU03847A IN2013MU03847A IN3847MU2013A IN2013MU03847A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A IN 3847MU2013 A IN3847MU2013 A IN 3847MU2013A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A
- Authority
- IN
- India
- Prior art keywords
- composition
- relates
- linagliptin
- devoid
- amino acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2014/000751 WO2015107536A2 (en) | 2013-12-09 | 2014-12-05 | Fixed dose combination comprising linagliptin and metformin hci |
IN3847MU2013 IN2013MU03847A (de) | 2013-12-09 | 2014-12-05 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3847MU2013 IN2013MU03847A (de) | 2013-12-09 | 2014-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03847A true IN2013MU03847A (de) | 2015-07-24 |
Family
ID=53543573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3847MU2013 IN2013MU03847A (de) | 2013-12-09 | 2014-12-05 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2013MU03847A (de) |
WO (1) | WO2015107536A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201721505A2 (tr) | 2017-12-25 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Li̇nagli̇pti̇n ve metformi̇n i̇çeren kombi̇nasyon |
TR201721824A2 (tr) * | 2017-12-26 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon |
CN117858703A (zh) | 2021-07-22 | 2024-04-09 | 新梅斯托克公司 | 用于制备包含利格列汀和盐酸二甲双胍的药物组合物的方法 |
CN116211819A (zh) * | 2023-04-12 | 2023-06-06 | 华润双鹤药业股份有限公司 | 一种利格列汀盐酸二甲双胍多层片及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR085689A1 (es) * | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
US9555001B2 (en) * | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
-
2014
- 2014-12-05 IN IN3847MU2013 patent/IN2013MU03847A/en unknown
- 2014-12-05 WO PCT/IN2014/000751 patent/WO2015107536A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015107536A2 (en) | 2015-07-23 |
WO2015107536A3 (en) | 2015-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502269A1 (en) | Quinazoline derivatives for the treatment of viral infections and further diseases | |
PH12016501139A1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
IN2014MN02069A (de) | ||
IN2014MN00948A (de) | ||
IN2014MN00986A (de) | ||
IN2014MN00987A (de) | ||
PH12014501984A1 (en) | Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor | |
IN2014MN02049A (de) | ||
PH12015500713B1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
IN2012MN02591A (de) | ||
IN2015DN01164A (de) | ||
MY181828A (en) | Bicyclically substituted uracils and the use therapy | |
MY182558A (en) | 1,2,4-triazine derivatives for the treatment of viral infections | |
IN2015DN01165A (de) | ||
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
IN2013MU03847A (de) | ||
PH12017501694A1 (en) | Compositions for the treatment of fibrosis and fibrosis-related diseases | |
PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
IN2014DN10683A (de) | ||
IN2013MU01223A (de) | ||
IN2013MU01222A (de) | ||
IN2013MU01225A (de) | ||
IN2013MU01224A (de) |